Filing Details

Accession Number:
0001661181-21-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-16 20:12:28
Reporting Period:
2021-02-11
Accepted Time:
2021-02-16 20:12:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661181 Organogenesis Holdings Inc. ORGO Biological Products, (No Disgnostic Substances) (2836) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1074084 Albert Erani C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
No No Yes No
1757286 A. Alan Ades C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
Yes No Yes No
1757452 Gn 2016 Organo 10-Year Grat U/A/D September 30, 2016 35 Sawgrass Drive
Bellport NY 11713
No No Yes No
1757453 Gn 2016 Family Trust U/A/D August 12, 2016 35 Sawgrass Drive
Bellport NY 11713
No No Yes No
1757455 12/20/12 Dated Trust Issue 2012 Erani Dennis C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
No No Yes No
1757567 Grat 2014 Ades Alan C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
No No Yes No
1757573 Organo Investors Llc C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
No No Yes No
1757580 Organo Pfg Llc C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
No No Yes No
1760663 12/29/2012 Dated Trust Family Erani Albert C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
No No Yes No
1760685 Dennis Erani C/O A&Amp;E Stores, Inc.
1000 Huyler Street
Teterboro NJ 07608
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2021-02-11 200,000 $3.25 68,594,976 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported securities sold were held directly by Alan A. Ades, who is a member of the Group (as defined below). On November 17, 2020, Mr. Ades purchased shares of Class A common stock of Organogenesis Holdings Inc. at a price of $3.25 per share, including (i) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of one of his sons and (ii) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of an entity that is managed by Mr. Ades' son-in-law. This Form 4 reflects the sales of such shares.